These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Ebola hemorrhagic fever and the threat it poses to health systems]. De la Hoz F Biomedica; 2014; 34(4):503-5. PubMed ID: 25504237 [No Abstract] [Full Text] [Related]
27. Vaccine hesitancy: Causes, consequences, and a call to action. Salmon DA; Dudley MZ; Glanz JM; Omer SB Vaccine; 2015 Nov; 33 Suppl 4():D66-71. PubMed ID: 26615171 [TBL] [Abstract][Full Text] [Related]
28. Ebola drug trials set to begin amid crisis. Butler D Nature; 2014 Sep; 513(7516):13-4. PubMed ID: 25186878 [No Abstract] [Full Text] [Related]
29. Editorial: Communicating vaccine safety - the Vienna Vaccine Safety Initiative. Rath B Curr Drug Saf; 2015; 10(1):3-4. PubMed ID: 25859667 [No Abstract] [Full Text] [Related]
30. Lessons from Ebola bring WHO reforms. Lough S CMAJ; 2015 Sep; 187(12):E377-8. PubMed ID: 26261198 [No Abstract] [Full Text] [Related]
31. Is the United Nations catching up with Ebola at last? Hawkes N; Arie S BMJ; 2014 Nov; 349():g6576. PubMed ID: 25378433 [No Abstract] [Full Text] [Related]
32. Role of the Red Cross movement in Uganda's Ebola outbreak. Sandbladh H Bull World Health Organ; 2001; 79(3):267. PubMed ID: 11285677 [No Abstract] [Full Text] [Related]
33. Ebola 2014--new challenges, new global response and responsibility. Frieden TR; Damon I; Bell BP; Kenyon T; Nichol S N Engl J Med; 2014 Sep; 371(13):1177-80. PubMed ID: 25140858 [No Abstract] [Full Text] [Related]
34. WHO's role in Ebola crisis is criticised by all sides. O'Dowd A BMJ; 2015 Nov; 351():h6385. PubMed ID: 26607657 [No Abstract] [Full Text] [Related]
35. [Ebola hemorrhagic fever: its extension reflects the African sanitary disaster]. Bourée P Rev Prat; 2014 Sep; 64(7):905-10. PubMed ID: 25362763 [TBL] [Abstract][Full Text] [Related]
36. End of the Ebola virus outbreak: time to reinforce the African health system and improve preparedness capacity. Mulinge I; Soyemi K Pan Afr Med J; 2016; 23():121. PubMed ID: 27279948 [No Abstract] [Full Text] [Related]
37. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. Henao-Restrepo AM; Longini IM; Egger M; Dean NE; Edmunds WJ; Camacho A; Carroll MW; Doumbia M; Draguez B; Duraffour S; Enwere G; Grais R; Gunther S; Hossmann S; Kondé MK; Kone S; Kuisma E; Levine MM; Mandal S; Norheim G; Riveros X; Soumah A; Trelle S; Vicari AS; Watson CH; Kéïta S; Kieny MP; Røttingen JA Lancet; 2015 Aug; 386(9996):857-66. PubMed ID: 26248676 [TBL] [Abstract][Full Text] [Related]
38. The Ebola outbreak in West Africa: a story of related public health challenges and a pointer to solutions to mitigate the inevitable next outbreak. Nsubuga P Pan Afr Med J; 2014; 19():48. PubMed ID: 25667710 [No Abstract] [Full Text] [Related]
39. Reconsidering the ethical permissibility of the use of unregistered interventions against Ebola virus disease. Landry JT; Foreman T; Kekewich M Camb Q Healthc Ethics; 2015 Jul; 24(3):366-9. PubMed ID: 26059962 [TBL] [Abstract][Full Text] [Related]